Quon, Peter L.
Xiao, Ying
Sorensen, Sonja
Monfared, Amir Abbas Tahami
Funding for this research was provided by:
Bristol-Myers Squibb Canada
Article History
First Online: 8 January 2019
Compliance with Ethical Standards
:
: Bristol-Myers Squibb, of Quebec, Canada, provided the funding for the study described in this manuscript and for the manuscript itself.
: At the time the study or analysis was conducted, Amir Abbas Tahami Monfared was an employee and shareholder of Bristol-Myers Squibb, Canada. This study was sponsored by Bristol-Myers Squibb. Peter Quon, Ying Xiao, and Sonja Sorensen are all employees of Evidera, which provides consulting and other research services to pharmaceutical, medical device, and other organizations. In their salaried positions, they work with a variety of companies and are precluded from receiving payment or honoraria directly from these organizations for services rendered. Evidera received funding from Bristol-Myers Squibb, of Quebec, Canada, for the involvement of their employees.
: PQ, YX, and SS designed and built the model, conducted the analyses, and interpreted the data. AATM and SS conceived the study and were in charge of overall direction and planning. All authors contributed to drafting the manuscript and approving the final version for submission. PQ serves as overall guarantor for this study and manuscript.
: For this type of study, formal consent is not required, so we did not submit our study to an independent ethics committee or institutional review board. This article does not contain any studies with human participants or animals performed by any of the authors.